Skip to main content

Jihye Park

Ewha Womans University · Medicine

About the Lab

Professor Jihye Park's research lab focuses on understanding the biological mechanisms underlying chronic diseases, particularly neurodegenerative disorders such as Parkinson’s disease and hematological malignancies like multiple myeloma. The lab employs advanced technologies such as single-cell RNA sequencing and preclinical disease models to dissect the tumor microenvironment and identify novel biomarkers for disease progression. Additionally, the lab investigates the long-term cardiovascular risks in cancer survivors and explores targeted therapeutic strategies, including receptor-based antiviral therapies for viral infections like human cytomegalovirus.

Parkinson's diseasemultiple myelomasingle-cell RNA sequencingcancer survivorsviral therapeutics

Research Overview

Papers
290
Total Citations
5,248
Papers (5y)
170
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
170total
2022
2023
2024
2025
2026
Citations per year (5y)
473total
20222023202420252026

Selected Papers

15
1
Article|64 citations·2015
Pain Perception in Acute Model Mice of Parkinson's Disease Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)
Jihye Park, Chae‐Seok Lim, Hyunhyo Seo, Chung-Ah Park, Min Zhuo, Bong‐Kiun Kaang, Kyungmin Lee
SJR Q1Molecular PainOA

BACKGROUND: Pain is the most prominent non-motor symptom observed in patients with Parkinson's disease (PD). However, the mechanisms underlying the generation of pain in PD have not been well studied. We used a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of PD to analyze the relationship between pain sensory abnormalities and the degeneration of dopaminergic neurons. RESULTS: The latency to fall off the rotarod and the total distance traveled in round chamber were sig

NeurologyMedicine
2
Article|43 citations·2018
Risk Factors for Cardiovascular Disease Among Thyroid Cancer Survivors: Findings From the Utah Cancer Survivors Study
Jihye Park, Brenna E. Blackburn, Patricia A. Ganz, Kerry Rowe, John Snyder, Yuan Wan, Vikrant Deshmukh, Michael Newman, Alison Fraser, Ken R. Smith, Kim Herget, Anne C. Kirchhoff
SJR Q1The Journal of Clinical Endocrinology & MetabolismOA

Context: Thyroid cancer survivors are at high risk of developing multiple cardiac and vascular conditions as consequence of cancer diagnosis and treatment. However, it is still unclear how the baseline and prognostic factors, as well as cancer treatments, play a role in increasing cardiac and vascular disease risk among thyroid cancer survivors. Objective: To investigate the association between potential risk factors, treatment effects, and cardiovascular disease (CVD) outcomes in thyroid cancer

Endocrinology, Diabetes and MetabolismMedicine
3
Article|32 citations·2018
Single-Cell RNA Sequencing Reveals Compromised Immune Microenvironment in Precursor Stages of Multiple Myeloma
Oksana Zavidij, Nicholas J. Haradhvala, Tarek H. Mouhieddine, Jihye Park, Romanos Sklavenitis Pistofidis, Mairéad Reidy, Daisy Huynh, Marzia Capelletti, Brianna Berrios, Mahshid Rahmat, Mark Bustoros, Chia‐Jen Liu
SJR Q1Blood

Abstract Introduction: In multiple myeloma (MM), despite well-characterized precursor states such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM), there is a lack of sufficient biomarkers to predict mechanisms of disease progression. Most genomic analyses have sought biomarkers by study of the malignant plasma cells, however, cancers form a complex ecosystem with the immune and stromal microenvironment. Thus, to characterize the cellular composi

HematologyMedicine
4
Article|25 citations·2018
Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma
Chia‐Jen Liu, Irene M. Ghobrial, Mark Bustoros, Kaitlen Reyes, Kalvis Hornburg, Ashraf Badros, James J. Vredenburgh, Adam Boruchov, Jeffrey Matous, Aaron M. Caola, Bradley Rivotto, Alexandra Savell
SJR Q1Blood

Abstract Background This study aimed to determine the benefit of early therapeutic intervention with the combination of elotuzumab, Lenalidomide, and Dexamethasone in patients with high-risk smoldering multiple myeloma (SMM). ClinicalTrials.gov Identifier: NCT02279394. Aims The overarching objective of this trial is to determine progression free survival to symptomatic multiple myeloma (MM). Furthermore, the study examined whether genomic studies can help in determining patients who would benefi

HematologyMedicine
5
Article|18 citations·2018
Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study
Jihye Park, Brenna E. Blackburn, Kerry Rowe, John Snyder, Yuan Wan, Vikrant Deshmukh, Michael Newman, Alison Fraser, Ken R. Smith, Kim Herget, Lindsay Burt, Theresa L. Werner
SJR Q1Annals of EpidemiologyOA
Reproductive MedicineMedicine
6
Article|16 citations·2020
Engineered receptors for human cytomegalovirus that are orthogonal to normal human biology
Jihye Park, Kevin S. Gill, Ali Asghar Aghajani, Jeremiah D. Heredia, Hannah Choi, Adam Oberstein, Erik Procko
SJR Q1PLoS PathogensOA

A trimeric glycoprotein complex on the surface of human cytomegalovirus (HCMV) binds to platelet-derived growth factor (PDGF) receptor α (PDGFRα) to mediate host cell recognition and fusion of the viral and cellular membranes. Soluble PDGFRα potently neutralizes HCMV in tissue culture, and its potential use as an antiviral therapeutic has the benefit that any escape mutants will likely be attenuated. However, PDGFRα binds multiple PDGF ligands in the human body as part of developmental programs

EpidemiologyMedicine
7
Article|8 citations·2015
The DNA Ligase IV Syndrome R278H Mutation Impairs B Lymphopoiesis via Error-Prone Nonhomologous End-Joining
Jihye Park, Robert S. Welner, Mei-Yee Chan, Logan Troppito, Philipp B. Staber, Daniel G. Tenen, Catherine T. Yan
SJR Q1The Journal of ImmunologyOA

Hypomorphic mutations in the nonhomologous end-joining (NHEJ) DNA repair protein DNA ligase IV (LIG4) lead to immunodeficiency with varying severity. In this study, using a murine knock-in model, we investigated the mechanisms underlying abnormalities in class switch recombination (CSR) associated with the human homozygous Lig4 R278H mutation. Previously, we found that despite the near absence of Lig4 end-ligation activity and severely reduced mature B cell numbers, Lig4(R278H/R278H) (Lig4(R/R))

Molecular BiologyBiochemistry, Genetics and Molecular Biology
8
Article|8 citations·2013
여대생의 사회지향성이 폭식행동에 미치는 영향: 정서조절 곤란의 조절효과를 중심으로
박지현, 방희정

본 연구는 여대생의 사회지향성과 폭식행동의 관계를 정서조절곤란과 그의 하위변인들이 조절하는 지를 알아보고자 하였다. 주요 변인들 간에는 모두 유의미한 정적 상관이 발견되었으며, 폭식행동에 대한 사회지향성과 정서조절곤란의 하위차원들의 설명력을 알아본 결과 사회지향성은 폭식행동을 유의미하게 설명하였다. 정서조절곤란의 하위차원 중 충동통제곤란, 정서에 대한 주의와 자각 부족, 정서에 대한 비수용성, 정서조절 전략에 대한 접근제한은 폭식행동에 유의미한 영향을 미치는 것으로 나타난 반면, 정서적 명료성의 부족과 목표지향 행동 수행의 어려움은 유의미한 설명력을 가지지 않는 것으로 나타났다. 마지막으로 정서조절곤란은 사회지향성과 폭식행동 관계를 조절하는 것으로 검증되었으며 정서조절곤란의 하위차원 중에서는 충동통제곤란과 정서적 명료성의 부족이 폭식행동에 대한 사회지향성의 영향력을 조절하는 것으로 나타났다.

9
Article|8 citations·2018
The Role of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Multiple Myeloma: Immunomodulator Maintenance Post Autologous Stem Cell Transplant (ASCT) Predicts Better Outcome
Tarek H. Mouhieddine, Jihye Park, Robert Redd, Christopher J. Gibson, Salomon Manier, Amin H. Nassar, Marzia Capelletti, Daisy Huynh, Mark Bustoros, Romanos Sklavenitis‐Pistofidis, Kalvis Hornburg, Henry Dumke
SJR Q1Blood

Abstract Introduction: Multiple Myeloma (MM) is a clonal plasma cell malignancy, accounting for 10% of all hematological malignancies. Genetic analyses of large populations revealed that blood-specific somatic mutations in hematopoietic stem cells (HSCs) are commonly acquired during aging, a new entity labeled: clonal hematopoiesis of indeterminate potential (CHIP). We sought to determine the role of CHIP on survival of MM patients, specifically those receiving immunomodulator (IMiD) maintenance

HematologyMedicine
10
Article|5 citations·2022
Patient characteristics and health system factors associated with adjuvant radiation therapy receipt in older women with early-stage endometrial cancer
Jihye Park, Jennifer L. Lund, Erin E. Kent, Chelsea Anderson, Wendy R. Brewster, Andrew F. Olshan, Hazel B. Nichols
SJR Q1Journal of Geriatric Oncology
Obstetrics and GynecologyMedicine
11
Article|2 citations·2018
Founding Precision Therapy in 1q-Amplified Multiple Myeloma
Romanos Sklavenitis‐Pistofidis, Mairéad Reidy, Daisy Huynh, Karma Z. Salem, Jihye Park, Siobhán Glavey, Xavier Leleu, David E. Root, Irene M. Ghobrial, Salomon Manier
SJR Q1Blood

Abstract Introduction Multiple myeloma is an incurable plasma cell malignancy with a strikingly heterogeneous genomic landscape. Other than IgH translocations and hyperdiploidy, only a few alterations are observed in large enough numbers. Amplification of the long arm of chromosome 1 (1q) is among the most common copy number alterations encountered, with a confirmed adverse effect on survival. Gene expression profiling has identified a minimal common amplified region between 1q21 and 1q23 as a p

HematologyMedicine
12
Article|2 citations·2018
Dissecting the Epigenetic Landscape of Smoldering, Newly Diagnosed and Relapsed Multiple Myeloma Revealed IRAK3 As a Marker of Disease Progression
Mahshid Rahmat, Nicholas J. Haradhvala, Romanos Sklavenitis‐Pistofidis, Jihye Park, Daisy Huynh, Mark Bustoros, Brianna Berrios, Mairéad Reidy, Adriana Perilla-Glen, Bradley Rivotto, Kalvis Hornburg, David M. Dorfman
SJR Q1Blood

Abstract Introduction. Multiple myeloma (MM) is a complex and heterogeneous malignancy of plasma cells that has two precursor states: monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). MGUS and SMM are asymptomatic states that eventually give rise to overt MM, with some patients progressing, while others do not. Recent studies in MM pathobiology have highlighted epigenetic alterations that contribute to the onset, progression and heterogeneity of MM.

HematologyMedicine
13
Article|2 citations·2016
Driver Mutation in Waldenstrom's Macroglobullinemia and Their Clonal Heterogeneity during Progression and Relapse
Jihye Park, Antonio Sacco, Salomon Manier, Karma Z. Salem, Mira Mashood, Adriana Perilla-Glen, Yosra Aljawai, Jiantao Shi, Eliezer M. Van Allen, Marzia Capelletti, Irene M. Ghobrial, Aldo M. Roccaro
SJR Q1Blood

Abstract Background: Whole genome sequencing has recently shown the presence of recurrent mutations, such as MYD88, CXCR4 and ARID1A, in patients with Waldenstrom's Macroglobulinemia (WM) at diagnosis. Nevertheless, the contribution of each genomic aberration within the clonal evolution of the tumor during WM progression has not been reported. We therefore aimed to investigate whether sequential genomic events sustain WM disease progression by using whole exome sequencing (WES) and targeted sequ

GeneticsMedicine
14
Article|2 citations·2013
비시정부와 청소년 교육 문화 정책
박지현

Notre étude est pour but d’examiner le rapport entre l’État et l’éducation sous le régime de Vichy à travers la politique de Jeunesse. Cette dernière était impliquée dans la politique éducative de la troisième République française. Elle était developpée au niveau de la structure administrative dans le gouvernement de Vichy. Ce dernier a voulu profiter de la politique de jeunesse pour convaincrer aux jeunes sa légitimité du pouvoir et pour leur propager son idéologie politique, «Révolution nation

15
Article|2 citations·2018
국방 무기체계 소프트웨어 신뢰성 향상을 위한 소프트웨어 동적 결함 분석
박지현, 최병주
정보처리학회 논문지

국방 무기체계에서의 소프트웨어 비중이 증가하고 있으며 구조도 점차 복잡해지고 있어, 이에 따른 신뢰성 검증이 매우 중요하다. 특히 무기체계 시스템을 구성하는 소프트웨어 구성 요소 들의 상호 작용에 따라 발생하는 결함은 정적 시험 및 코드 실행률 점검 수준의 동적 시험만으로는예방하기가 어렵다. 본 논문에서는 소프트웨어의 동적 결함 유형을 분류 개발한다. 미 국방부 무기체계에 사용하는 오픈 소스 소프트웨어(OSS)에서 보고된 이슈 분석을 통하여 본 논문에서 분류한 동적 결함이 실제로 발생하며, 이들은 대체로 통합 이후 발생하는 결함이며, 재현이 어렵고, 결함 원인 파악이 어려웠음을 보인다. 이 분석 결과를 기반으로 무기체계 신뢰성 검증을 위하여 소프트웨어 통합 시험 개선의 중요성을 도출한다.

Research Areas

Molecular BiologyHematologyOncologyPulmonary and Respiratory MedicineCancer ResearchEpidemiology

Dive deeper into Jihye Park's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.